Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis
Alexia Verroken, Anaïs Scohy, Ludovic Gérard, Xavier Wittebole, Christine Collienne, Pierre-François Laterre
Abstract
International guidelines recommend the initiation of empirical antibiotherapy for possible associated bacterial pneumonia in COVID-19 critically ill yet further suggesting a rapid reassessment upon source documentation [1]. In this prospective cohort analysis, we investigated the respiratory co-infection rate in COVID-19 critically ill through the use of rapid molecular testing and measured its impact on antibiotic management. [...]
Topics & Concepts
MedicineCritically illCoronavirus disease 2019 (COVID-19)Intensive care medicineProspective cohort studyAntibiotics2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Emergency medicineInternal medicineVirologyInfectious disease (medical specialty)OutbreakMicrobiologyDiseaseBiologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19